Medical Technology

Veradigm leverages AI to enhance real-world evidence for GLP-1 drugs, revealing insights on patient adherence, side effects, and treatment outcomes.

AccurKardia's AccurECG wins "Best New Technology Solution for ECG," revolutionizing cardiac diagnostics with AI-driven, real-time ECG analysis for better patient outcomes.

Osteoboost introduces a groundbreaking FDA-cleared device for osteoporosis, offering innovative, non-invasive therapy to enhance bone health and prevent fractures.

Imperative Care enhances stroke treatment with Zoom DuoPort, enabling efficient dual aspiration for faster, more effective thrombectomy procedures.

BrightHeart's FDA-cleared AI platform enhances fetal heart screenings, improving detection of congenital heart defects during ultrasounds with real-time analysis.

Learn how enhanced interoperability in EHR systems transforms patient care, reduces costs, and improves outcomes across health care settings.

NextGen Healthcare partners with Madison Dearborn Partners to enhance growth and innovation in ambulatory health care technology solutions.

The Jewel Patch-WCD offers a discreet solution for patients at risk of cardiac arrest, enhancing safety and daily life integration.

GE HealthCare showcases strong Q1 earnings with revenue growth, strategic acquisitions, and new product launches, despite adjusting full-year guidance due to tariffs.

Machine learning, a subfield of artificial intelligence, can sift through massive amounts of data to benefit physicians and patients.

Scott Whitaker says tariff-free trade is critical to maintaining the industry’s competitiveness and ensuring patient access to lifesaving products

CorWave advances heart failure treatment with a groundbreaking LVAD, showcasing promising preclinical results and paving the way for human trials.

This is the first time an implantable, long-term EEG monitoring device has been authorized for use in the United States.

The company received the designation for its atrioventricular interval modulation therapy, a novel pacemaker-based treatment aimed at reducing blood pressure in patients with uncontrolled hypertension and elevated cardiovascular risk.

Move positions Zimmer Biomet in the foot and ankle space

Ohio State researchers develop system that analyzes health by how they walk

Key considerations around selecting the right network partner include what the partner will do with the data, the interoperability partner’s experience and expertise, the quality and the usability of the data it will deliver, and the partner’s financial strength.

Robotic removal of blood clots could dramatically change stroke care

Mark E. Rosenberg, MD, FASN, dean of the American University of the Caribbean School of Medicine, shares his perspectives on education, Match 2025 and more.

The newly cleared system uses advanced identification and antimicrobial susceptibility testing algorithms to support the interpretation of complex microbiological data.

$8 billion division grew 4.1% for the quarter

Experts say the lack of a consistent payment mechanism through Medicare has become a major roadblock to adoption.

RSP Systems achieves major milestone in non-invasive glucose monitoring technology

The impact of these tariffs on the global market has been significant. What's next for investors?

Are your patients' medications about to get more expensive?

American Heart Association says physicians should consider how digital drivers of health affect patients.

The company also expects to submit its application for 510(k) clearance for its OneRF Trigeminal Nerve Ablation System in May, sooner than expected.

Swiss-based company’s plant will increase capacity to meet demand for autoinjectors

Between President Trump's tariff plan and sweeping layoffs at the FDA and HSS, the medical device industry is facing an uncertain future.

Under the terms, Boston Scientific will pay about $443 million upfront, plus up to $221 million if regulatory milestones occur.